StockData
Mesa Laboratories Inc logo

Mesa Laboratories Inc (MLAB) stock

MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3071% above fair value
$135.20−4.01 (-2.88%)

Close on Nov 12, 2026Market cap $756.56MP/E 117.6Yield 0.47%

Mesa Laboratories gross margin

Gross margin is gross profit as a percentage of revenue.

Mesa Laboratories's gross margin for the twelve months ending Sep 30, 2026 was 64.8%. For fiscal 2026 it was 63.5%, against 62.6% the year before. The highest annual figure on record is 65.0% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 202663.5%+0.9
FY2025Mar 31, 202562.6%+1.0
FY2024Mar 31, 202461.6%+0.6
FY2023Mar 31, 202361.0%+1.8
FY2022Mar 31, 202259.2%−5.8
FY2021Mar 31, 202165.0%+9.4
FY2020Mar 31, 202055.5%−3.5
FY2019Mar 31, 201959.1%+2.3
FY2018Mar 31, 201856.8%−0.1
FY2017Mar 31, 201756.8%−3.9
FY2016Mar 31, 201660.7%−0.1
FY2015Mar 31, 201560.8%+0.7
FY2014Mar 31, 201460.1%−2.1
FY2013Mar 31, 201362.2%+2.8
FY2012Mar 31, 201259.3%+2.2
FY2011Mar 31, 201157.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2027CQ3 2026Sep 30, 202664.0%+2.5
Q1 FY2027CQ2 2026Jun 30, 202664.9%+2.8
Q4 FY2026CQ1 2026Mar 31, 202666.2%+4.4
Q3 FY2026CQ4 2025Dec 31, 202564.2%+0.9
Q2 FY2026CQ3 2025Sep 30, 202561.5%+0.2
Q1 FY2026CQ2 2025Jun 30, 202562.0%−2.0
Q4 FY2025CQ1 2025Mar 31, 202561.8%−0.2
Q3 FY2025CQ4 2024Dec 31, 202463.3%+0.8
Q2 FY2025CQ3 2024Sep 30, 202461.3%+0.9
Q1 FY2025CQ2 2024Jun 30, 202464.0%+2.5
Q4 FY2024CQ1 2024Mar 31, 202462.1%+2.3
Q3 FY2024CQ4 2023Dec 31, 202362.5%+2.1
Q2 FY2024CQ3 2023Sep 30, 202360.4%−1.5
Q1 FY2024CQ2 2023Jun 30, 202361.6%−0.5
Q4 FY2023CQ1 2023Mar 31, 202359.7%+0.1
Q3 FY2023CQ4 2022Dec 31, 202260.4%+8.0
Q2 FY2023CQ3 2022Sep 30, 202261.9%−2.6
Q1 FY2023CQ2 2022Jun 30, 202262.1%−1.5
Q4 FY2022CQ1 2022Mar 31, 202259.6%−5.5
Q3 FY2022CQ4 2021Dec 31, 202152.3%−8.1
Q2 FY2022CQ3 2021Sep 30, 202164.6%−2.2
Q1 FY2022CQ2 2021Jun 30, 202163.6%−4.3
Q4 FY2021CQ1 2021Mar 31, 202165.2%+10.3
Q3 FY2021CQ4 2020Dec 31, 202060.4%+13.7
Q2 FY2021CQ3 2020Sep 30, 202066.8%+5.8
Q1 FY2021CQ2 2020Jun 30, 202067.9%+6.3
Q4 FY2020CQ1 2020Mar 31, 202054.9%−4.2
Q3 FY2020CQ4 2019Dec 31, 201946.8%−11.8
Q2 FY2020CQ3 2019Sep 30, 201961.0%+2.4
Q1 FY2020CQ2 2019Jun 30, 201961.6%+1.6
Q4 FY2019CQ1 2019Mar 31, 201959.0%−0.6
Q3 FY2019CQ4 2018Dec 31, 201858.6%+5.0
Q2 FY2019CQ3 2018Sep 30, 201858.6%+1.0
Q1 FY2019CQ2 2018Jun 30, 201860.0%+4.1
Q4 FY2018CQ1 2018Mar 31, 201859.6%+2.2
Q3 FY2018CQ4 2017Dec 31, 201753.6%−3.2
Q2 FY2018CQ3 2017Sep 30, 201757.7%–
Q1 FY2018CQ2 2017Jun 30, 201755.9%–
Q4 FY2017CQ1 2017Mar 31, 201757.5%–
Q3 FY2017CQ4 2016Dec 31, 201656.8%–

More Mesa Laboratories figures

See a number that looks wrong?